PMID- 29674046 OWN - NLM STAT- MEDLINE DCOM- 20180924 LR - 20180924 IS - 1873-3573 (Electronic) IS - 0039-9140 (Linking) VI - 184 DP - 2018 Jul 1 TI - Development of a chromatographic method with multi-criteria decision making design for simultaneous determination of nifedipine and atenolol in content uniformity testing. PG - 296-306 LID - S0039-9140(18)30240-6 [pii] LID - 10.1016/j.talanta.2018.03.008 [doi] AB - A new robust and reliable high-performance liquid chromatography (HPLC) method with multi-criteria decision making (MCDM) approach was developed to allow simultaneous quantification of atenolol (ATN) and nifedipine (NFD) in content uniformity testing. Felodipine (FLD) was used as an internal standard (I.S.) in this study. A novel marriage between a new interactive response optimizer and a HPLC method was suggested for multiple response optimizations of target responses. An interactive response optimizer was used as a decision and prediction tool for the optimal settings of target responses, according to specified criteria, based on Derringer's desirability. Four independent variables were considered in this study: Acetonitrile%, buffer pH and concentration along with column temperature. Eight responses were optimized: retention times of ATN, NFD, and FLD, resolutions between ATN/NFD and NFD/FLD, and plate numbers for ATN, NFD, and FLD. Multiple regression analysis was applied in order to scan the influences of the most significant variables for the regression models. The experimental design was set to give minimum retention times, maximum resolution and plate numbers. The interactive response optimizer allowed prediction of optimum conditions according to these criteria with a good composite desirability value of 0.98156. The developed method was validated according to the International Conference on Harmonization (ICH) guidelines with the aid of the experimental design. The developed MCDM-HPLC method showed superior robustness and resolution in short analysis time allowing successful simultaneous content uniformity testing of ATN and NFD in marketed capsules. The current work presents an interactive response optimizer as an efficient platform to optimize, predict responses, and validate HPLC methodology with tolerable design space for assay in quality control laboratories. CI - Copyright (c) 2018 Elsevier B.V. All rights reserved. FAU - Ahmed, Sameh AU - Ahmed S AD - Pharmacognosy and Pharmaceutical Chemistry Department, College of Pharmacy Taibah University, Al Madinah AlMunawarah 30001, Saudi Arabia; Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Assiut University, Assiut 71526, Egypt. Electronic address: shassan@taibahu.edu.sa. FAU - Alqurshi, Abdulmalik AU - Alqurshi A AD - Pharmaceutics and Pharmaceutical Technology Department, College of Pharmacy Taibah University, Al Madinah AlMunawarah 30001, Saudi Arabia. FAU - Mohamed, Abdel-Maaboud Ismail AU - Mohamed AI AD - Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Assiut University, Assiut 71526, Egypt. LA - eng PT - Journal Article DEP - 20180307 PL - Netherlands TA - Talanta JT - Talanta JID - 2984816R RN - 0 (Tablets) RN - 50VV3VW0TI (Atenolol) RN - I9ZF7L6G2L (Nifedipine) SB - IM MH - Atenolol/*analysis MH - Chromatography, High Pressure Liquid/*methods MH - *Decision Making MH - *Drug Compounding MH - Nifedipine/*analysis MH - Tablets/chemistry OTO - NOTNLM OT - Atenolol OT - Content uniformity testing OT - HPLC OT - Multi-criteria decision making OT - Nifidipine OT - Response Optimizer EDAT- 2018/04/21 06:00 MHDA- 2018/09/25 06:00 CRDT- 2018/04/21 06:00 PHST- 2018/01/28 00:00 [received] PHST- 2018/03/03 00:00 [revised] PHST- 2018/03/05 00:00 [accepted] PHST- 2018/04/21 06:00 [entrez] PHST- 2018/04/21 06:00 [pubmed] PHST- 2018/09/25 06:00 [medline] AID - S0039-9140(18)30240-6 [pii] AID - 10.1016/j.talanta.2018.03.008 [doi] PST - ppublish SO - Talanta. 2018 Jul 1;184:296-306. doi: 10.1016/j.talanta.2018.03.008. Epub 2018 Mar 7.